Article info

Download PDFPDF
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia
  1. Correspondence to Professor Achille Pich, Department of Biomedical Sciences and Human Oncology, Section of Pathology, University of Turin, Via Santena 7, I-10126 Torino, Italy; achille.pich{at}unito.it
View Full Text

Citation

Pich A, Riera L, Sismondi F, et al
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia

Publication history

  • Accepted May 18, 2009
  • First published September 4, 2009.
Online issue publication 
September 04, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.